Table of Contents
Chapter 1.Executive Summary
1.1.Market Snapshot
1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1.Spine Biologics Market, by Region, 2020-2030 (USD Billion)
1.2.2.Spine Biologics Market, by Product, 2020-2030 (USD Billion)
1.2.3.Spine Biologics Market, by End-use, 2020-2030 (USD Billion)
1.3.Key Trends
1.4.Estimation Methodology
1.5.Research Assumption
Chapter 2.Global Spine Biologics Market Definition and Scope
2.1.Objective of the Study
2.2.Market Definition & Scope
2.2.1.Industry Evolution
2.2.2.Scope of the Study
2.3.Years Considered for the Study
2.4.Currency Conversion Rates
Chapter 3.Global Spine Biologics Market Dynamics
3.1.Spine Biologics Market Impact Analysis (2020-2030)
3.1.1.Market Drivers
3.1.1.1.Increase in geriatric population
3.1.1.2.Rising prevalence of spine disorders
3.1.2.Market Challenges
3.1.2.1.Reimbursement issues
3.1.2.2.High cost of bone graft procedures
3.1.3.Market Opportunities
3.1.3.1.Increase in advancements in bone grafting procedures
3.1.3.2.Rising inclination towards minimally invasive procedures
Chapter 4.Global Spine Biologics Market Industry Analysis
4.1.Porter's 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.2.Porter's 5 Force Impact Analysis
4.3.PEST Analysis
4.3.1.Political
4.3.2.Economical
4.3.3.Social
4.3.4.Technological
4.3.5.Environmental
4.3.6.Legal
4.4.Top investment opportunity
4.5.Top winning strategies
4.6.COVID-19 Impact Analysis
4.7.Disruptive Trends
4.8.Industry Expert Perspective
4.9.Analyst Recommendation & Conclusion
Chapter 5.Global Spine Biologics Market, by Product
5.1.Market Snapshot
5.2.Global Spine Biologics Market by Product, Performance - Potential Analysis
5.3.Global Spine Biologics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4.Spine Biologics Market, Sub Segment Analysis
5.4.1.Spinal Allografts
5.4.2.Bone Graft Substitutes
5.4.3.Cell-base Matrix
Chapter 6.Global Spine Biologics Market, by End-use
6.1.Market Snapshot
6.2.Global Spine Biologics Market by End-use, Performance - Potential Analysis
6.3.Global Spine Biologics Market Estimates & Forecasts by End-use 2020-2030 (USD Billion)
6.4.Spine Biologics Market, Sub Segment Analysis
6.4.1.Hospitals
6.4.2.Ambulatory Surgical Centers
Chapter 7.Global Spine Biologics Market, Regional Analysis
7.1.Top Leading Countries
7.2.Top Emerging Countries
7.3.Spine Biologics Market, Regional Market Snapshot
7.4.North America Spine Biologics Market
7.4.1.U.S. Spine Biologics Market
7.4.1.1.Product breakdown estimates & forecasts, 2020-2030
7.4.1.2.End-use breakdown estimates & forecasts, 2020-2030
7.4.2.Canada Spine Biologics Market
7.5.Europe Spine Biologics Market Snapshot
7.5.1.U.K. Spine Biologics Market
7.5.2.Germany Spine Biologics Market
7.5.3.France Spine Biologics Market
7.5.4.Spain Spine Biologics Market
7.5.5.Italy Spine Biologics Market
7.5.6.Rest of Europe Spine Biologics Market
7.6.Asia-Pacific Spine Biologics Market Snapshot
7.6.1.China Spine Biologics Market
7.6.2.India Spine Biologics Market
7.6.3.Japan Spine Biologics Market
7.6.4.Australia Spine Biologics Market
7.6.5.South Korea Spine Biologics Market
7.6.6.Rest of Asia Pacific Spine Biologics Market
7.7.Latin America Spine Biologics Market Snapshot
7.7.1.Brazil Spine Biologics Market
7.7.2.Mexico Spine Biologics Market
7.8.Middle East & Africa Spine Biologics Market
7.8.1.Saudi Arabia Spine Biologics Market
7.8.2.South Africa Spine Biologics Market
7.8.3.Rest of Middle East & Africa Spine Biologics Market
Chapter 8.Competitive Intelligence
8.1.Key Company SWOT Analysis
8.2.Top Market Strategies
8.3.Company Profiles
8.3.1.Stryker
8.3.1.1.Key Information
8.3.1.2.Overview
8.3.1.3.Financial (Subject to Data Availability)
8.3.1.4.Product Summary
8.3.1.5.Recent Developments
8.3.2.NuVasive, Inc.
8.3.3.Orthofix
8.3.4.DePuy Synthes (Johnson & Johnson)
8.3.5.Exactech, Inc.
8.3.6.Zimmer Biomet
8.3.7.Arthrex, Inc.
8.3.8.Medtronic
8.3.9.Organogenesis Inc.
8.3.10.Kuros Biosciences.
Chapter 9.Research Process
9.1.Research Process
9.1.1.Data Mining
9.1.2.Analysis
9.1.3.Market Estimation
9.1.4.Validation
9.1.5.Publishing
9.2.Research Attributes
9.3.Research Assumption